Within the framework of the Hospital Future Act (KHZG), a campus license for a medication management system as well as the necessary services regarding project management/customizing/implementation and training are procured. In addition, system services for the medication management system are also put out to tender. The procurement of the medication management system will take place as a provision of standard software for a one-time fee on a permanent basis (purchase).

LOT-0001
MHH - Medication Management System.
The current paper-based medication process is error-prone, time-consuming and costly. A digital medication management system is intended to increase patient safety and improve documentation processes. Due to the redundant data collection, the effort for documentation during patient admission, stay and interventions is currently immense and entails associated unnecessary time expenditure for the service provider. Furthermore, there is a claim to ensure the safe and timely availability of current medication for all departments and downstream organizational units. Therefore, the central availability of medication documentation is essential for patient, legal and process safety. Digital medication documentation is one of the most important documents from the point of view of liability in patient treatment.

The introduction of a digital medication management system is intended to improve documentation, process quality and patient safety throughout the hospital. The introduction of digital medication software is an integral part of MHH's digitalization strategy.

Planned project implementation phases on the part of MHH:
- Phase 1: the piloting of the software solution is to be introduced in a maximum of two clinics and then evaluated. Launch one month after the infrastructure is deployed.
- Phase 2: the software will be rolled out in two more clinics and in the central emergency department.
- Phase 3: the software is offered to the clinics and institutes MHH-wide and supported by MHH IT (MIT) in the implementation. This phase is expected to end at the end of 2026 with a penetration > 85% of the clinics and institutes (wards, outpatient clinics) in relation to the total number of clinics and institutes (wards and outpatient clinics) to be converted.